Ashlee Joseph

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Ejection Fraction

Diffuse Large B Cell Lymphoma

Chronic Lymphocytic Leukemia

Top Venues

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Clare Grieve, Ashlee Joseph, Pamela Drullinsky, Andrew D Zelenetz, Paul Hamlin, Anita Kumar
Phase I study of bendamustine, rituximab, ibrutinib, and venetoclax in relapsed, refractory mantle cell lymphoma. Leukemia & lymphoma 65 (2) (2024)
Ashwath Gurumurthi, Kurt S Bantilan, Paul A Hamlin, Anita Kumar, Matthew J Matasar, Menglei Zhu, Ashlee Joseph, Ali Castro, Erin Biggar, Gilles Andre Salles, Andrew D Zelenetz, Gottfried von Keudell
A phase 1 trial of abexinostat with ibrutinib in relapsed/refractory mantle cell lymphoma and non-germinal center diffuse large B cell lymphoma. Leukemia & lymphoma (2024)
Clare Grieve, Ashlee Joseph, Pamela Drullinsky, Andrew D Zelenetz, Paul Hamlin, Anita Kumar
Phase I study of bendamustine, rituximab, ibrutinib, and venetoclax in relapsed, refractory mantle cell lymphoma. Leukemia & lymphoma 65 (2) (2024)
Clare Grieve, Ashlee Joseph, Pamela Drullinsky, Andrew D Zelenetz, Paul Hamlin, Anita Kumar
Phase I study of bendamustine, rituximab, ibrutinib, and venetoclax in relapsed, refractory mantle cell lymphoma. Leukemia & lymphoma 65 (2) (2024)
Anita Kumar, Carla Casulo, Erel Joffe, Craig Moskowitz, John Gerecitano, Alison Moskowitz, Anas Younes, Pamela Drullinsky, Esther Drill, Morgan Choma, Clare Grieve, Ashlee Joseph, Leana Laraque, Dylan Schick, Andrew D Zelenetz, Paul Hamlin
Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design. Leukemia & lymphoma 63 (12) (2022)